- Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal ratP E Stieg
CNS Research Institute, Neurosurgical Service, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Eur J Pharmacol 375:115-20. 1999..0001). At this dosage, memantine manifests few, if any, neurobehavioral side effects. Thus memantine appears to be both safe and effective in neonatal as well as adult animal models of stroke...